RECRUITING

A Center Based Early Intervention Program for Preschoolers with Developmental Disorders

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to examine the effectiveness of a 12-week early intervention program that will include 12 weekly hours in an intensive center-based preschool environment or in the home to treat social communication deficits in children with developmental disorders. The study will include children with developmental disorders, such as Autism Spectrum Disorder, neurogenetic disorders, or intellectual disability.

Official Title

A Center Based Early Intervention Program for Preschoolers with Developmental Disorders

Quick Facts

Study Start:2019-10-19
Study Completion:2034-12-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04026386

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:2 Years to 5 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * Diagnosis of Developmental Disorder, such as Autism Spectrum Disorder, neurogenetic disorder, or intellectual disability, based on clinical interview;
  2. * Boys and girls between 2.0 years and 5.11 years at time of enrollment;
  3. * Ability to participate in the testing procedures to the extent that valid standard scores can be obtained.
  1. * Current or lifetime diagnosis of severe psychiatric disorder (e.g., bipolar disorder, etc.);
  2. * Lack of availability during program hours.

Contacts and Locations

Study Contact

Madeleine Clark, BS
CONTACT
(650) 736-1235
mclark11@stanford.edu
Robin Libove, BS
CONTACT
(650) 736-1235
rlibove@stanford.edu

Principal Investigator

Antonio Hardan, MD
PRINCIPAL_INVESTIGATOR
Stanford University

Study Locations (Sites)

Stanford University School of Medicine
Stanford, California, 94305
United States

Collaborators and Investigators

Sponsor: Stanford University

  • Antonio Hardan, MD, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-10-19
Study Completion Date2034-12-30

Study Record Updates

Study Start Date2019-10-19
Study Completion Date2034-12-30

Terms related to this study

Additional Relevant MeSH Terms

  • Development Disorder, Child
  • Developmental Disability
  • Development Delay
  • Autism Spectrum Disorder